MALINC1 and breast cancer: Furthermore, Fabre and colleagues showed that MALINC1 behaves as an ER-modulated transcript predominantly found in the cytoplasmic compartment of luminal-like mammary cells that may influence BC progression, affecting patient prognosis, including response to hormone therapy [72].